Corpus Intelligence IC Memo — CAMDEN GENERAL HOSPITAL 2026-04-26 17:26 UTC
IC Memo — CAMDEN GENERAL HOSPITAL
Investment Committee Memorandum | TN | 25 beds | Grade D | EBITDA uplift $757K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CAMDEN GENERAL HOSPITAL

CCN 441316 | BENTON, TN | 25 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

CAMDEN GENERAL HOSPITAL is a 25-bed community hospital in BENTON, TN with $10.2M in net patient revenue and a 6.5% operating margin. The hospital serves a payer mix of 61.2% Medicare, 0.0% Medicaid, and 38.8% commercial.

Thesis: Turnaround. Our ML models identify $757K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 6.5% to 13.9% (+742bps).

Net Revenue HCRIS$10.2M
Current EBITDA COMPUTED$662K
Operating Margin COMPUTED6.5%
Occupancy HCRIS11.1%
Revenue / Bed COMPUTED$408K
Net-to-Gross HCRIS33.2%
Distress Probability MLnan%

2. Market Context & Competitive Position

141
TN Hospitals
-0.6%
State Median Margin
55
Comparable Hospitals

TN has 141 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of 6.5% places it above the state median. Among 55 size-comparable peers (12-50 beds), the median margin is -0.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 55 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CAMDEN GENERAL HOSPITAL (Target)TN25$10.2M6.5%
BAPTIST MEM HOSPITAL TIPTON COTN48$179.0M-5.8%
INDIAN PATH COMMUNITY HOSPITALTN35$142.8M12.0%
HENRY COUNTY MEDICAL CENTERTN43$81.7M-13.0%
THE CENTER FOR SPINAL SURGERYTN23$78.7M39.3%
TRUSTPOINT HOSPITALTN18$50.8M-0.8%
BAPTIST MEM HOSPITAL UNION CITTN43$50.5M5.1%
VANDERBILT BEDFORD COUNTY HOSPTN24$49.5M1.9%
NEWPORT MEDICAL CENTERTN32$47.8M11.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $757K (742bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$214K+210bp18mo
Denial Rate Reduction12.0%6.5%$205K+201bp12mo
Cost to Collect4.5%2.5%$204K+200bp12mo
A/R Days Reduction5200.0%3800.0%$124K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+9bp6mo

5. EBITDA Bridge

Net Collection Rate
$214K
Denial Rate Reduction
$205K
Cost to Collect
$204K
A/R Days Reduction
$124K
Clean Claim Rate
$10K
Total EBITDA Uplift$757K
Current EBITDA$662K
+ RCM Uplift+$757K
Pro Forma EBITDA$1.4M
Current Margin6.5%
Pro Forma Margin13.9%
WC Released (1x)$392K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$1.0M$11.9M11.72x63.6%
Base (11x exit)10.0x11.0x$1.0M$13.5M13.21x67.6%
Bull Case9.0x11.0x$917K$16.3M17.77x77.8%
Bull (12x exit)9.0x12.0x$917K$18.0M19.68x81.5%
Bear Case11.0x10.0x$1.1M$7.8M6.98x47.5%
Bear (11x exit)11.0x11.0x$1.1M$9.0M8.00x51.6%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 61.2% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
MediumLow occupancyAt 11.1%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 55 hospitals with 12-50 beds
  • Same-state prioritization (n=56)
  • Comp margins: P25=-14.4% / P50=-0.8% / P75=9.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.